查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713343

2025年恒温核酸增幅技术（INAAT）全球市场报告

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

恒温核酸增幅技术（INAAT）市场规模预计将在未来几年快速成长。到 2029 年，这一数字将成长至 75.1 亿美元，复合年增长率为 14.6%。预测期内的成长可归因于大流行病防范、抗生素抗药性、环境监测、肿瘤诊断和全球健康计划。预测期内的关键趋势包括多路復用、小型化、数位检测、样本到答案系统和基因编辑整合。

感染疾病和慢性病的盛行率上升是恒温核酸增幅技术（INAAT）市场扩张的主要驱动力。流感嗜血桿菌、肺炎链球菌（呼吸道感染疾病）、淋病奈瑟菌、沙眼衣原体（生殖器感染疾病）和结核病等疾病正在增加，需要恒温核酸增幅技术（INAAT）等诊断解决方案。根据世界卫生组织 (WHO) 统计，每年约有 1000 万人患有肺结核，150 万人死于肺结核。感染疾病和慢性病的日益普及正在刺激恒温核酸增幅技术市场的扩张。

政府针对医疗保健研究和开发的倡议预计将显着推动恒温核酸增幅技术市场的未来成长。这些倡议包括政府机构为解决各种医疗保健问题而采取的具体行动、计划和政策，包括对恒温核酸增幅技术的支援。 2022 年，英国卫生和社会保障部 (DHSC) 宣布拨款 2.6 亿英镑（2.7065 亿美元）用于促进医疗保健研究和製造业。该资金由英国商业、能源和工业战略部 (BEIS) 和 DHSC 设立，将促进 NHS主导的医学研究、诊断和治疗的隐私保护平台，并加强英国的生命科学製造业。因此，政府专注于医学研发的措施正在推动恒温核酸增幅技术市场的发展。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球恒温核酸增幅技术（INAAT）PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球恒温核酸增幅技术（INAAT）市场：成长率分析
  • 全球恒温核酸增幅技术 (INAAT) 市场表现：规模与成长，2019-2024 年
  • 全球恒温核酸增幅技术 (INAAT) 市场预测：规模与成长，2024-2029 年，2034 年
  • 全球恒温核酸增幅技术 (INAAT) 总目标市场 (TAM)

第六章市场区隔

  • 全球恒温核酸增幅技术 (INAAT) 市场：按产品、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 装置
  • 试剂
  • 全球恒温核酸增幅技术 (INAAT) 市场：按技术、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • NASBA
  • HAD
  • 全球恒温核酸增幅技术 (INAAT) 市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 血液检查
  • 感染疾病诊断
  • 癌症
  • 全球恒温核酸增幅技术 (INAAT) 市场（按最终用户、性能和预测），2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 参考实验室
  • 其他最终用户
  • 全球恒温核酸增幅技术 (INAAT) 市场、仪器细分、类型、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 可携式设备
  • 桌上型装置
  • 全球恒温核酸增幅技术 (INAAT) 市场，按试剂类型细分，性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 酵素
  • 引子和探针
  • 缓衝液和其他试剂

第七章 区域和国家分析

  • 全球恒温核酸增幅技术（INAAT）市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球恒温核酸增幅技术 (INAAT) 市场：按国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 恒温核酸增幅技术 (INAAT) 市场：竞争格局
  • 恒温核酸增幅技术 (INAAT) 市场：公司简介
    • Alere Inc. Overview, Products and Services, Strategy and Financial Analysis
    • biomeriux SA Overview, Products and Services, Strategy and Financial Analysis
    • Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickson & Company Overview, Products and Services, Strategy and Financial Analysis
    • Hologica Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Lucigen Corporation
  • Quidel Corporation
  • New England Biolabs Inc.
  • NuGen
  • Ustar Biotechnologies Ltd.
  • Thermo Fisher Scientific Inc.
  • BioHelix Corporation
  • Meridian Bioscience Inc.
  • Novartis AG
  • Sharp Corporation
  • Sony Corporation
  • Panasonic Holdings Corporation
  • Toshiba Corporation
  • Rohm Co Ltd.
  • PhilipsHologic-Gen-Probe

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年恒温核酸增幅技术（INAAT）市场：提供新机会的国家
  • 2029年恒温核酸增幅技术（INAAT）市场：细分领域带来新机会
  • 恒温核酸增幅技术（INAAT）市场2029年：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r32621

Isothermal nucleic acid amplification technology (INAAT) is a method employed for amplifying DNA samples. INAAT enables the amplification of DNA sequences from two different nucleic acid segments at a constant temperature.

The primary product types associated with isothermal nucleic acid amplification technology include instruments and reagents. Reagents are substances or compounds introduced into a system to induce a chemical reaction or to determine whether a reaction has occurred. Various technologies, such as NASBA and HAD, are used in this context and are typically applied in areas like blood screening, infectious disease diagnostics, and cancer-related analyses. The end users of this technology encompass hospitals, reference laboratories, and other institutions.

The isothermal nucleic acid amplification technology (INAAT) market research report is one of a series of new reports from The Business Research Company that provides isothermal nucleic acid amplification technology (INAAT) market statistics, including isothermal nucleic acid amplification technology (INAAT) industry global market size, regional shares, competitors with a isothermal nucleic acid amplification technology (INAAT) market share, detailed isothermal nucleic acid amplification technology (INAAT) market segments, market trends and opportunities, and any further data you may need to thrive in the isothermal nucleic acid amplification technology (INAAT) industry. This isothermal nucleic acid amplification technology (INAAT) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The isothermal nucleic acid amplification technology (INAAT) market size has grown rapidly in recent years. It will grow from $3.94 billion in 2024 to $4.34 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to infectious disease diagnostics, point-of-care testing (poct), tuberculosis control, molecular diagnostics, emerging markets.

The isothermal nucleic acid amplification technology (INAAT) market size is expected to see rapid growth in the next few years. It will grow to $7.51 billion in 2029 at a compound annual growth rate (CAGR) of 14.6%. The growth in the forecast period can be attributed to pandemic preparedness, antimicrobial resistance, environmental monitoring, oncology diagnostics, global health initiatives. Major trends in the forecast period include multiplexing, miniaturization, digital detection, sample-to-answer systems, gene editing integration.

The rising incidence of Infectious and Chronic Diseases is a significant driver behind the expansion of the Isothermal Nucleic Acid Amplification Technology (INAAT) market. Diseases such as H. influenzae, S. pneumonia (respiratory tract infections), N. gonorrhoeae, C. trachomatis (genital infections), and TB are on the increase, demanding diagnostic solutions like isothermal nucleic acid amplification technology (INAAT). According to the World Health Organization (WHO), an estimated 10 million people contract tuberculosis every year, resulting in 1.5 million deaths. The growing prevalence of infectious and chronic diseases is a key factor fueling the expansion of the isothermal nucleic acid amplification technology market.

Government initiatives aimed at healthcare research and development are poised to significantly drive the growth of the isothermal nucleic acid amplification technology market in the future. These initiatives involve specific actions, programs, or policies launched by government entities to tackle various healthcare issues, including supporting isothermal nucleic acid amplification technology. In 2022, the UK's Department of Health and Social Care (DHSC) announced a £260 million ($270.65 million) funding commitment to foster healthcare research and manufacturing. This funding, established by the Department for Business, Energy and Industrial Strategy (BEIS) and DHSC, aims to facilitate NHS-led health research, privacy-preserving platforms for diagnostics and treatments, and bolster life sciences manufacturing in the UK. Hence, government initiatives focused on healthcare research and development are propelling the isothermal nucleic acid amplification technology market.

Nanostructures are increasingly integrated into in vitro diagnostics and in vitro rapid diagnostic tests (RDTs) to enhance existing tests' effectiveness and develop innovative diagnostic approaches for point-of-care applications. Nanostructures and nanotechnology employ nanoparticles to improve drug actions in treatments. Nanotechnology entails designing, characterizing, producing, and applying devices, structures, and systems by precisely manipulating size and shape at the nanometer scale. Several RDTs have been created for syphilis diagnosis, such as AccuBioTech (Accu-Tell Rapid Syphilis Test), Alere, Inc. (Alere Determine), Alere/Standard Diagnostics (SD Syphilis 3.0), The Tulip Group/Qualpro (Syphicheck - WB), Cypress Diagnostics (Syphilis Rapid Test), and Omega Diagnostics (Visitect Syphilis). These RDTs enable patients to receive diagnoses at the point of care (POC).

Major companies operating in the isothermal nucleic acid amplification technology market are developing innovative solutions like the QIAstat-Dx syndromic testing solution to gain a competitive advantage. The QIAstat-Dx system is an integrated, multiplexed molecular testing platform that combines sample preparation, nucleic acid amplification, and detection within a single cartridge. For instance, in April 2023, Qiagen, a Netherlands-based company specializing in isothermal nucleic acid amplification technology (INAAT) for various applications, introduced the QIAstat-Dx syndromic testing solution. This system provides Ct (cycle threshold) values and access to amplification curves, allowing clinicians to monitor amplification progress and make well-informed diagnostic decisions.

In February 2023, Sherlock Biosciences, a U.S.-based biotechnology company, acquired Sense Biodetection for an undisclosed amount. This acquisition allows Sherlock to enhance its diagnostic capabilities by integrating Sense's LAMP-based technology with its advanced CRISPR methodologies, thereby improving the speed and accessibility of molecular testing. Sense Biodetection, a UK-based company, specializes in developing rapid, point-of-care diagnostic solutions that utilize isothermal nucleic acid amplification technology, particularly Loop-Mediated Isothermal Amplification (LAMP).

Major companies operating in the isothermal nucleic acid amplification technology (inaat) market include Alere Inc., biomeriux SA, Qiagen NV, Becton, Dickson & Company, Hologica Inc., Lucigen Corporation, Quidel Corporation, New England Biolabs Inc., NuGen, Ustar Biotechnologies Ltd., Thermo Fisher Scientific Inc., BioHelix Corporation, Meridian Bioscience Inc., Novartis AG, Sharp Corporation, Sony Corporation, Panasonic Holdings Corporation, Toshiba Corporation, Rohm Co Ltd., PhilipsHologic-Gen-Probe, BetaLED, Avago Technologies Ltd., Grifols SA, Abbott Laboratories, Jena Bioscience GmbH, Atila Biosystems Incorporated, TwistDx Ltd., LGC Ltd., DiaSorin SpA, OptiGene Limited

North America was the largest region in the isothermal nucleic acid amplification technology (INAAT) market in 2024. Western Europe was the second largest region in the isothermal nucleic acid amplification technology (INAAT) market. The regions covered in the isothermal nucleic acid amplification technology (inaat) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the isothermal nucleic acid amplification technology (inaat) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The isothermal nucleic acid amplification technology (INAAT) market includes revenues earned by reaction systems and related services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on isothermal nucleic acid amplification technology (inaat) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for isothermal nucleic acid amplification technology (inaat) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The isothermal nucleic acid amplification technology (inaat) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Instrument; Reagent
  • 2) By Technology: NASBA; HAD
  • 3) By Application: Blood Screening; Infectious Disease Diagnostics; Cancer
  • 4) By End-User: Hospital; Reference Laboratories; Other End-Users
  • Subsegments:
  • 1) By Instrument: Portable Instruments; Benchtop Instruments
  • 2) By Reagent: Enzymes; Primers And Probes; Buffers And Other Reagents
  • Companies Mentioned: Alere Inc.; biomeriux SA; Qiagen NV; Becton, Dickson & Company; Hologica Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Characteristics

3. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends And Strategies

4. Isothermal Nucleic Acid Amplification Technology (INAAT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate Analysis
  • 5.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Total Addressable Market (TAM)

6. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Segmentation

  • 6.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instrument
  • Reagent
  • 6.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NASBA
  • HAD
  • 6.3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Screening
  • Infectious Disease Diagnostics
  • Cancer
  • 6.4. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Reference Laboratories
  • Other End-Users
  • 6.5. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Instruments
  • Benchtop Instruments
  • 6.6. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Sub-Segmentation Of Reagent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzymes
  • Primers and Probes
  • Buffers and Other Reagents

7. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Regional And Country Analysis

  • 7.1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 8.1. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 9.1. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 9.2. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 10.1. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 11.1. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 11.2. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 12.1. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 13.1. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 14.1. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 14.2. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 15.1. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 15.2. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 16.1. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 17.1. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 18.1. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 19.1. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 20.1. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 21.1. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 21.2. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 22.1. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 23.1. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 23.2. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 24.1. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 24.2. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 25.1. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 25.2. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 26.1. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 26.2. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 27.1. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 28.1. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 28.2. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market

  • 29.1. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Overview
  • 29.2. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape And Company Profiles

  • 30.1. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Landscape
  • 30.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Company Profiles
    • 30.2.1. Alere Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. biomeriux SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Becton, Dickson & Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Hologica Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Other Major And Innovative Companies

  • 31.1. Lucigen Corporation
  • 31.2. Quidel Corporation
  • 31.3. New England Biolabs Inc.
  • 31.4. NuGen
  • 31.5. Ustar Biotechnologies Ltd.
  • 31.6. Thermo Fisher Scientific Inc.
  • 31.7. BioHelix Corporation
  • 31.8. Meridian Bioscience Inc.
  • 31.9. Novartis AG
  • 31.10. Sharp Corporation
  • 31.11. Sony Corporation
  • 31.12. Panasonic Holdings Corporation
  • 31.13. Toshiba Corporation
  • 31.14. Rohm Co Ltd.
  • 31.15. PhilipsHologic-Gen-Probe

32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

34. Recent Developments In The Isothermal Nucleic Acid Amplification Technology (INAAT) Market

35. Isothermal Nucleic Acid Amplification Technology (INAAT) Market High Potential Countries, Segments and Strategies

  • 35.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer